Click here to register.
Download the 2009 announcement here.
Submit an
abstract here.
2010 conference information coming soon!
Save the date:
December 9-12, 2010
Hollywood, Florida
The Westin Diplomat
Continuing Medical Education
Physicians: Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum 16.75 of AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurses: This educational activity has been submitted to the Society of Gastroenterology Nurses and Associates, Inc. for approval. The Society of Gastroenterology Nurses and Associates, Inc. is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Who Should Attend
This activity is intended for gastroenterologists, internists, nurses, surgeons, basic science researchers, clinical researchers, and other health care professionals with an interest in the treatment of pediatric and adult patients with IBD.
Objectives
After attending this conference, clinicians and practitioners should be able to:
- Review significant advances in therapeutic options for the treatment of IBD, particularly biologics and immunomodulators
- Recall advantages and disadvantages of current pharmacological therapies for IBD
- Discuss emerging basic science research related to IBD, especially in the fields of genetics, immunology, microbiology, and oncology
- Describe evolving patient management and treatment strategies for intestinal and extraintestinal complications in IBD
- Analyze a variety of diagnostic images obtained by modern endoscopic techniques
- Distinguish between strategy options for treating children and adolescents with IBD
- Recommend disease management options based on case presentations from national IBD thought leaders
- Identify the most appropriate surgical techniques in the treatment of IBD
After attending this conference, nurses should be able to:
- Discuss wound and ostomy management strategies for patients with IBD.
- Describe the management of IBD patients with fecal incontinence and perineal dermatitis
After attending this conference, basic scientists and researchers should be able to:
- Review significant advances in therapeutic options for the treatment of IBD, particularly biologics and immunomodulators
- Discuss emerging basic science research in fields outside their own, especially genetics, immunology, microbiology, and cell biology
- Identify and explain at least 2 unanswered research questions related to IBD from the fields of microbiology, genetics, and immunology
- Summarize the genetic underpinnings of inflammatory disorders like IBD
- Restate recent advances in understanding epithelial cellbacterial interactions in IBD
- Outline current knowledge of immune system regulation in IBD, especially the action of cytokines including IL-13 and IL-23
